Transforming clinical trials in rheumatology: towards patient-centric precision medicine

Pitzalis, Costantino, Choy, Ernest H. S. ORCID: https://orcid.org/0000-0003-4459-8609 and Buch, Maya H. 2020. Transforming clinical trials in rheumatology: towards patient-centric precision medicine. Nature Reviews Rheumatology 16 (10) , pp. 590-599. 10.1038/s41584-020-0491-4

Preview

PDF Available under License Creative Commons Attribution. Download (499kB) | Preview

Abstract

Despite the success of targeted therapies in the treatment of inflammatory arthritides, the lack of predictive biomarkers drives a ‘trial and error’ approach to treatment allocation, leading to variable and/or unsatisfactory responses. In-depth characterization of the synovial tissue in rheumatoid arthritis, as well as psoriatic arthritis and spondyloarthritis, is bringing new insights into the diverse cellular and molecular features of these diseases and their potential links with different clinical and treatment-response phenotypes. Such progress raises the tantalizing prospect of improving response rates by matching the use of specific agents to the cognate target pathways that might drive particular disease subtypes in specific patient groups. Innovative patient-centric, molecular pathology-driven clinical trial approaches are needed to achieve this goal. Whilst progress is clearly being made, it is important to emphasize that this field is still in its infancy and there are a number of potential barriers to realizing the premise of patient-centric clinical trials.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Nature Publishing Group
ISSN:	1759-4790
Date of Acceptance:	4 August 2020
Last Modified:	03 May 2023 09:29
URI:	https://orca.cardiff.ac.uk/id/eprint/136030

Citation Data

Cited 23 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item